145 related articles for article (PubMed ID: 18430260)
1. NHERF1: molecular brake on the PI3K pathway in breast cancer.
Georgescu MM
Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260
[TBL] [Abstract][Full Text] [Related]
2. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
Pan Y; Weinman EJ; Dai JL
Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
[TBL] [Abstract][Full Text] [Related]
3. NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.
Georgescu MM; Cote G; Agarwal NK; White CL
Neoplasia; 2014 Apr; 16(4):365-74.e1-2. PubMed ID: 24862762
[TBL] [Abstract][Full Text] [Related]
4. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma.
Molina JR; Agarwal NK; Morales FC; Hayashi Y; Aldape KD; Cote G; Georgescu MM
Oncogene; 2012 Mar; 31(10):1264-74. PubMed ID: 21804599
[TBL] [Abstract][Full Text] [Related]
5. PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling.
Takahashi Y; Morales FC; Kreimann EL; Georgescu MM
EMBO J; 2006 Feb; 25(4):910-20. PubMed ID: 16456542
[TBL] [Abstract][Full Text] [Related]
6. Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation.
Molina JR; Morales FC; Hayashi Y; Aldape KD; Georgescu MM
Cancer Res; 2010 Sep; 70(17):6697-703. PubMed ID: 20736378
[TBL] [Abstract][Full Text] [Related]
7. Roles of NHERF1/EBP50 in cancer.
Georgescu MM; Morales FC; Molina JR; Hayashi Y
Curr Mol Med; 2008 Sep; 8(6):459-68. PubMed ID: 18781953
[TBL] [Abstract][Full Text] [Related]
8. Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance.
Vaquero J; Nguyen Ho-Bouldoires TH; Clapéron A; Fouassier L
Oncogene; 2017 Jun; 36(22):3067-3079. PubMed ID: 28068322
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.
Saponaro C; Malfettone A; Dell'Endice TS; Brunetti AE; Achimas-Cadariu P; Paradiso A; Mangia A
Cancer Biomark; 2014; 14(2-3):177-84. PubMed ID: 24878819
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
Cheng S; Li Y; Yang Y; Feng D; Yang L; Ma Q; Zheng S; Meng R; Wang S; Wang S; Jiang WG; He J
FEBS Lett; 2013 Oct; 587(20):3289-95. PubMed ID: 24012959
[TBL] [Abstract][Full Text] [Related]
11. EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway.
Li H; Zhang B; Liu Y; Yin C
Med Oncol; 2014 Sep; 31(9):162. PubMed ID: 25119502
[TBL] [Abstract][Full Text] [Related]
12. NHERF1/EBP50 head-to-tail intramolecular interaction masks association with PDZ domain ligands.
Morales FC; Takahashi Y; Momin S; Adams H; Chen X; Georgescu MM
Mol Cell Biol; 2007 Apr; 27(7):2527-37. PubMed ID: 17242191
[TBL] [Abstract][Full Text] [Related]
13. Ezrin-radixin-moesin-binding phosphoprotein-50 regulates EGF-induced AKT activation through interaction with EGFR and PTEN.
Zheng J; Dai Y; Yang Z; Yang L; Peng Z; Meng R; Xiong Y; He J
Oncol Rep; 2016 Jan; 35(1):530-7. PubMed ID: 26531778
[TBL] [Abstract][Full Text] [Related]
14. Repressing of NHERF1 inhibits liver cancer progression by promoting the production of ROS.
Sun J; Li P; Yang J
Biochem Biophys Res Commun; 2019 Jan; 509(1):8-15. PubMed ID: 30581004
[TBL] [Abstract][Full Text] [Related]
15. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
[TBL] [Abstract][Full Text] [Related]
16. NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.
Georgescu MM; Mobley BC; Orr BA; Shang P; Lehman NL; Zhu X; O'Neill TJ; Rajaram V; Hatanpaa KJ; Timmons CF; Raisanen JM
Acta Neuropathol Commun; 2016 May; 4(1):55. PubMed ID: 27229317
[TBL] [Abstract][Full Text] [Related]
17. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.
Cardone RA; Bellizzi A; Busco G; Weinman EJ; Dell'Aquila ME; Casavola V; Azzariti A; Mangia A; Paradiso A; Reshkin SJ
Mol Biol Cell; 2007 May; 18(5):1768-80. PubMed ID: 17332506
[TBL] [Abstract][Full Text] [Related]
18. A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression.
Yang X; Du G; Yu Z; Si Y; Martin TA; He J; Cheng S; Jiang WG
Anticancer Res; 2017 Jan; 37(1):67-73. PubMed ID: 28011475
[TBL] [Abstract][Full Text] [Related]
19. Ezrin induces long-range interdomain allostery in the scaffolding protein NHERF1.
Li J; Callaway DJ; Bu Z
J Mol Biol; 2009 Sep; 392(1):166-80. PubMed ID: 19591839
[TBL] [Abstract][Full Text] [Related]
20. Specificity of NHERF1 regulation of GPCR signaling and function in human airway smooth muscle.
Pera T; Tompkins E; Katz M; Wang B; Deshpande DA; Weinman EJ; Penn RB
FASEB J; 2019 Aug; 33(8):9008-9016. PubMed ID: 31042404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
